Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B288827-5mg | 5mg | In stock | $93.90 | |
B288827-10mg | 10mg | In stock | $137.90 | |
B288827-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $424.90 | |
B288827-100mg | 100mg | In stock | $692.90 |
Potent dual MCT1/2 inhibitor
Synonyms | 2-[[2-Chloro-5-(phenylsulfonyl)benzoyl]amino]benzoic acid |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of Monocarboxylate transporter 1;Inhibitor of Monocarboxylate transporter 2 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-[[5-(benzenesulfonyl)-2-chlorobenzoyl]amino]benzoic acid |
---|---|
INCHI | InChI=1S/C20H14ClNO5S/c21-17-11-10-14(28(26,27)13-6-2-1-3-7-13)12-16(17)19(23)22-18-9-5-4-8-15(18)20(24)25/h1-12H,(H,22,23)(H,24,25) |
InChi Key | CLAUJSRBKSRTGQ-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)S(=O)(=O)C2=CC(=C(C=C2)Cl)C(=O)NC3=CC=CC=C3C(=O)O |
Isomeric SMILES | C1=CC=C(C=C1)S(=O)(=O)C2=CC(=C(C=C2)Cl)C(=O)NC3=CC=CC=C3C(=O)O |
PubChem CID | 992293 |
MeSH Entry Terms | 2-(((2-chloro-5-(phenylsulfonyl)phenyl)-carbonyl)amino)benzoic acid;BAY-8002 |
Molecular Weight | 415.85 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2113379 | Certificate of Analysis | Jul 18, 2024 | B288827 |
J2113380 | Certificate of Analysis | Jul 18, 2024 | B288827 |
J2113381 | Certificate of Analysis | Jul 18, 2024 | B288827 |
J2113382 | Certificate of Analysis | Jul 18, 2024 | B288827 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 41.58, Max Conc. mM: 100 |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. |
1. Quanz M, Bender E, Kopitz C, Grünewald S, Schlicker A, Schwede W, Eheim A, Toschi L, Neuhaus R, Richter C et al.. (2018) Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.. Mol Cancer Ther, 17 (11): (2285-2296). [PMID:30115664] |